Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH

Sitting for More Than 10 Hours Daily Ups Heart Disease Risk

Cardiologist examines the latest breakthroughs in coronary inflammation research

Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment

SAVR linked to higher 10-year survival rate than TAVR for low-risk patients

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

NeuroVascular Quality Initiative Quality Outcomes Database (NVQI-QOD) Celebrates 25,000th Procedure Milestone

Can Cardiac Coherence Improve Health?